You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cladribine

Showing 1 - 25 of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Cladribine
  • +4 more
  • (no location specified)
Mar 1, 2023

Cladribine Therapy After Anti CD20 Therapy

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine Oral Tablet
  • +2 more
  • Lugano, Ticino, Switzerland
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugan
Mar 22, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 12, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 11, 2021

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Saint Louis (Cladribine)

Recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 1, 2021

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • (no location specified)
Apr 8, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)

Active, not recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Cladribine
  • +2 more
  • Bochum, Germany
  • +6 more
Feb 8, 2022

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Cladribine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 3, 2022

Multiple Sclerosis Trial in Latham (Cladribine Tablets)

Recruiting
  • Multiple Sclerosis
  • Cladribine Tablets
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
    • Coventry, United Kingdom
    • +7 more
    May 20, 2022

    Langerhans Cell Histiocytosis of Lung Trial in Paris (Cladribine)

    Active, not recruiting
    • Langerhans Cell Histiocytosis of Lung
    • Cladribine
    • Paris, France
      Saint Louis hospital
    Feb 17, 2021

    Acute Myeloid Leukemia MDS Trial in Gliwice (Cladribine)

    Not yet recruiting
    • Acute Myeloid Leukemia Myelodysplastic Syndromes
    • Cladribine
    • Gliwice, Poland
      Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytu
    May 3, 2021

    Seasonal Influenza Vaccination in Multiple Sclerosis Patients

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Vaccine Response Impaired
    • Most recent vaccine to seasonal influenza
    • Duesseldorf, Northrhine-Westphalia, Germany
      Medical Faculty, Heinrich-Heine-University
    Aug 19, 2021

    Multiple Sclerosis Trial in Rouen (biological collection)

    Recruiting
    • Multiple Sclerosis
    • biological collection
    • Rouen, France
      Rouen University Hospital
    Mar 25, 2021

    Secondary Acute Myeloid Leukemia Trial in Houston (Cladribine, Cytarabine, Uproleselan)

    Recruiting
    • Secondary Acute Myeloid Leukemia
    • Cladribine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 25, 2021

    Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)

    Recruiting
    • Peripheral T-cell Lymphoma
    • BEAC
    • Cladribine combined with BEAC
    • Shanghai, Shanghai, China
      Ruijin Hospital
    May 9, 2021

    Advanced Multiple Sclerosis, Progressive Multiple Sclerosis Trial in United Kingdom (Cladribine (MAVENCLAD®), Placebo)

    Recruiting
    • Advanced Multiple Sclerosis
    • Progressive Multiple Sclerosis
    • Cladribine (MAVENCLAD®)
    • Placebo
    • Belfast, United Kingdom
    • +18 more
    Jun 9, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 18, 2021

    Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed Trial in Guangzhou (Cladribine Injection, Aclarubicin, G-CSF)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Cladribine Injection
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Dec 15, 2020

    Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • CAV Regimen
    • MEC Regimen
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Dec 22, 2022

    Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

    Completed
    • Multiple Sclerosis
    • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
    • Prague, Czechia
      IMPULS Endowment Fund
    Mar 7, 2023

    Leukemia Trial in Shanghai (CLAM+PBSC)

    Suspended
    • Leukemia
    • Shanghai, China
      Rui Jin Hospital, Department of Hematology
    Nov 23, 2021